1. Home
  2. CGON vs SBCF Comparison

CGON vs SBCF Comparison

Compare CGON & SBCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • SBCF
  • Stock Information
  • Founded
  • CGON 2010
  • SBCF 1926
  • Country
  • CGON United States
  • SBCF United States
  • Employees
  • CGON N/A
  • SBCF N/A
  • Industry
  • CGON
  • SBCF Major Banks
  • Sector
  • CGON
  • SBCF Finance
  • Exchange
  • CGON NYSE
  • SBCF Nasdaq
  • Market Cap
  • CGON 2.1B
  • SBCF 2.1B
  • IPO Year
  • CGON 2024
  • SBCF N/A
  • Fundamental
  • Price
  • CGON $26.90
  • SBCF $29.55
  • Analyst Decision
  • CGON Strong Buy
  • SBCF Buy
  • Analyst Count
  • CGON 10
  • SBCF 4
  • Target Price
  • CGON $64.44
  • SBCF $29.25
  • AVG Volume (30 Days)
  • CGON 868.1K
  • SBCF 693.4K
  • Earning Date
  • CGON 08-07-2025
  • SBCF 07-24-2025
  • Dividend Yield
  • CGON N/A
  • SBCF 2.44%
  • EPS Growth
  • CGON N/A
  • SBCF 6.66
  • EPS
  • CGON N/A
  • SBCF 1.48
  • Revenue
  • CGON $662,000.00
  • SBCF $506,381,000.00
  • Revenue This Year
  • CGON N/A
  • SBCF $23.90
  • Revenue Next Year
  • CGON $25,206.93
  • SBCF $25.88
  • P/E Ratio
  • CGON N/A
  • SBCF $19.96
  • Revenue Growth
  • CGON 224.51
  • SBCF N/A
  • 52 Week Low
  • CGON $14.80
  • SBCF $21.36
  • 52 Week High
  • CGON $40.47
  • SBCF $31.68
  • Technical
  • Relative Strength Index (RSI)
  • CGON 59.29
  • SBCF 78.81
  • Support Level
  • CGON $25.51
  • SBCF $27.13
  • Resistance Level
  • CGON $27.28
  • SBCF $26.33
  • Average True Range (ATR)
  • CGON 1.01
  • SBCF 0.70
  • MACD
  • CGON 0.02
  • SBCF 0.41
  • Stochastic Oscillator
  • CGON 89.23
  • SBCF 92.21

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.

Share on Social Networks: